Suppr超能文献

免疫抑制对狒狒(埃及狒狒)子宫内膜异位症发生发展的影响。

The effects of immunosuppression on development and progression of endometriosis in baboons (Papio anubis).

作者信息

D'Hooghe T M, Bambra C S, Raeymaekers B M, De Jonge I, Hill J A, Koninckx P R

机构信息

Department of Reproduction, Institute of Primate Research, Nairobi, Kenya.

出版信息

Fertil Steril. 1995 Jul;64(1):172-8.

PMID:7789554
Abstract

OBJECTIVE

To test the hypothesis that immunosuppression increases the development and progression of endometriosis in baboons.

DESIGN

Experimental controlled study.

SETTING

Institute of Primate Research, Nairobi, Kenya.

PARTICIPANTS

Thirty-two baboons (8 with normal pelvis, 10 with spontaneous endometriosis, and 14 with endometriosis induced by intraperitoneal seeding of menstrual endometrium).

INTERVENTION

Daily injection of 0.8 mg/kg IM methylprednisolone and 2 mg/kg azathioprine for 3 months in 16 baboons (4 with normal pelvis, 5 with spontaneous endometriosis, and 7 with induced endometriosis). No treatment was given to the remaining 16 primates.

MAIN OUTCOME MEASURES

The change in number and surface area (mm2) of endometriotic lesions was evaluated by laparoscopy in all baboons after 3 months, in 8 animals with induced endometriosis and in 9 primates with spontaneous disease after 7 and 12 months, respectively.

RESULTS

Immunosuppressed baboons with spontaneous endometriosis had a significantly higher number and larger surface area of endometriotic lesions than nontreated animals. However, immunosuppressed and nontreated primates with induced endometriosis were comparable with respect to both number and surface area of implants. A transient decrease in typical lesions was noted during immunosuppression. Immunosuppression did not cause the development of endometriosis in baboons with previously documented normal pelvis.

CONCLUSION

Immunosuppression may increase the progression of endometriosis in baboons with spontaneous disease.

摘要

目的

验证免疫抑制会增加狒狒子宫内膜异位症的发生和发展这一假说。

设计

实验对照研究。

地点

肯尼亚内罗毕灵长类动物研究所。

研究对象

32只狒狒(8只骨盆正常,10只患有自发性子宫内膜异位症,14只通过腹腔接种月经子宫内膜诱导产生子宫内膜异位症)。

干预措施

16只狒狒(4只骨盆正常,5只患有自发性子宫内膜异位症,7只患有诱导性子宫内膜异位症)每日肌注0.8mg/kg甲泼尼龙和2mg/kg硫唑嘌呤,持续3个月。其余16只灵长类动物不给予治疗。

主要观察指标

3个月后对所有狒狒进行腹腔镜检查,评估子宫内膜异位症病变数量和表面积(mm²)的变化;分别在7个月和12个月后,对8只诱导性子宫内膜异位症动物和9只自发性疾病灵长类动物进行评估。

结果

患有自发性子宫内膜异位症的免疫抑制狒狒,其子宫内膜异位症病变数量和表面积显著高于未治疗动物。然而,患有诱导性子宫内膜异位症的免疫抑制和未治疗的灵长类动物在植入物数量和表面积方面相当。免疫抑制期间,典型病变出现短暂减少。免疫抑制并未导致先前骨盆记录正常的狒狒发生子宫内膜异位症。

结论

免疫抑制可能会增加患有自发性疾病的狒狒子宫内膜异位症的进展。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验